CoChat

MRI in Neuromuscular Diseases: An Emerging Diagnostic Tool and Biomarker for Prognosis and Efficacy

Dahlqvist, Julia R., Widholm, Per, Leinhard, Olof Dahlqvist, Vissing, John · 2020 · Annals of Neurology
Cited by 90

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

There is an unmet need to identify biomarkers sensitive to change in rare, slowly progressive neuromuscular diseases. Quantitative magnetic resonance imaging (MRI) of muscle may offer this opportunity, as it is noninvasive and can be carried out almost independent of patient cooperation and disease severity. Muscle fat content correlates with muscle function in neuromuscular diseases, and changes in fat content precede changes in function, which suggests that muscle MRI is a strong biomarker candidate to predict prognosis and treatment efficacy. In this paper, we review the evidence suggesting that muscle MRI may be an important biomarker for diagnosis and to monitor change in disease severity. ANN NEUROL 2020;88:669–681

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.25804

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 86

  1. 10.1002/mus.880110202 · doi:10.1002/mus.880110202
  2. 10.1016/0895-6111(89)90210-3 · doi:10.1016/0895-6111(89)90210-3
  3. 10.1002/jmri.21492 · DOI · Paper page
  4. 10.1007/s00415-017-8547-3 · DOI · Paper page
  5. 10.1016/j.nmd.2009.02.009 · DOI
  6. 10.3233/JND-180333 · DOI
  7. 10.1016/S0960-8966(02)00023-8 · DOI · Paper page
  8. 10.1212/WNL.0b013e318208811f · doi:10.1212/wnl.0b013e318208811f
  9. 10.1371/journal.pone.0070993 · DOI · Paper page
  10. 10.1002/jmri.24726 · DOI · Paper page
  11. 10.1371/journal.pone.0038779 · DOI
  12. 10.1016/j.nmd.2015.05.006 · DOI
  13. 10.1371/journal.pone.0192495 · DOI · Paper page
  14. 10.2165/00007256-200838120-00003 · DOI · Paper page
  15. 10.1038/s41598-020-64287-8 · DOI
  16. 10.1111/joim.12234 · DOI
  17. 10.1007/s11845-017-1714-9 · DOI
  18. 10.1002/hep.29797 · DOI · Paper page
  19. 10.1016/j.jhep.2016.04.021 · DOI · Paper page
  20. 10.4103/0366-6999.186638 · doi:10.4103/0366-6999.186638
  21. 10.1016/j.ejrad.2015.06.011 · doi:10.1016/j.ejrad.2015.06.011
  22. 10.1136/jnnp-2017-316736 · doi:10.1136/jnnp-2017-316736
  23. 10.1155/2018/3710814 · doi:10.1155/2018/3710814
  24. 10.1371/journal.pone.0090377 · DOI
  25. 10.1002/mus.24569 · DOI
  26. 10.1212/WNL.0000000000000828 · DOI
  27. 10.1212/WNL.0000000000006887 · DOI
  28. 10.1002/mus.25385 · doi:10.1002/mus.25385
  29. 10.1212/WNL.0000000000008009 · DOI
  30. Holm‐Yildiz S, Permanent muscle weakness in hypokalemic periodic paralysis, Neurology
  31. 10.1212/WNL.0000000000009068 · DOI
  32. 10.1007/s00415-012-6733-x · DOI
  33. 10.1371/journal.pone.0194283 · DOI
  34. 10.1007/s00256-011-1301-5 · DOI
  35. 10.1007/s00256-011-1240-1 · DOI
  36. 10.1016/j.nmd.2016.07.013 · DOI
  37. 10.1002/ana.24599 · DOI · Paper page
  38. 10.1212/WNL.0000000000004647 · DOI
  39. 10.1007/s00415-016-8361-3 · DOI
  40. 10.1371/journal.pone.0085416 · DOI
  41. 10.1007/s00415-018-9037-y · DOI
  42. 10.1002/ana.24743 · DOI
  43. 10.1002/mus.26189 · DOI
  44. 10.1002/ana.25345 · doi:10.1002/ana.25345
  45. Hooijmans MT, 2017, Elevated phosphodiester and T2 levels can be measured in the absence of fat infiltration in Duchenne muscular dystrophy patients, NMR Biomed, 30, 10.1002/nbm.3667 · DOI
  46. 10.1002/mus.26038 · DOI
  47. Gershman A, 2016, A randomized, double‐blinded, placebo‐controlled, multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and biological activity of ATYR1940 in adult patients with facioscapulohumeral muscular dystrophy (FSHD), Neuromuscul Disord, 26, S167, 10.1016/j.nmd.2016.06.293 · doi:10.1016/j.nmd.2016.06.293
  48. 10.1016/j.ejpn.2007.02.018 · DOI
  49. 10.1212/WNL.0000000000008168 · DOI
  50. 10.3233/JND-180341 · DOI
  51. 10.1007/s00415-011-5937-9 · doi:10.1007/s00415-011-5937-9
  52. 10.1002/acn3.406 · DOI
  53. 10.1002/acn3.774 · doi:10.1002/acn3.774
  54. 10.1212/WNL.0000000000000775 · DOI
  55. 10.1016/S1474-4422(18)30320-X · DOI
  56. 10.1212/WNL.0000000000002640 · DOI
  57. 10.1016/S0197-2456(02)00234-9 · DOI
  58. 10.1016/j.nmd.2014.01.015 · DOI · Paper page
  59. 10.1016/j.nmd.2011.06.750 · DOI
  60. 10.1016/j.nmd.2017.11.017 · DOI
  61. 10.1002/nbm.4119 · DOI
  62. 10.1212/WNL.0000000000006214 · DOI
  63. 10.1007/s00415-016-8350-6 · DOI
  64. 10.1055/s-0034-1389894 · doi:10.1055/s-0034-1389894
  65. 10.1016/j.arthro.2015.06.035 · DOI
  66. 10.1016/j.arthro.2015.11.008 · DOI
  67. Baudin PY, 2012, Prior knowledge, random walks and human skeletal muscle segmentation, Med Image Comput Comput, 15, 569
  68. 10.1007/s10334-016-0535-6 · DOI
  69. 10.2214/AJR.07.2732 · DOI · Paper page
  70. 10.1002/mus.880040304 · DOI · Paper page
  71. 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M · DOI · Paper page
  72. 10.1148/radiol.10091547 · DOI · Paper page
  73. 10.1002/mus.880060502 · DOI
  74. 10.1002/nbm.2851 · DOI
  75. 10.1136/jnnp-2013-306350 · DOI
  76. 10.1016/j.nmd.2016.04.009 · doi:10.1016/j.nmd.2016.04.009
  77. 10.1007/s00415-016-8311-0 · DOI
  78. 10.1038/s41598-019-41240-y · DOI
  79. 10.1007/s00415-011-6393-2 · DOI
  80. 10.1016/j.nmd.2013.12.012 · DOI
  81. 10.1002/mus.24629 · DOI
  82. 10.1212/WNL.0000000000002464 · DOI
  83. 10.1371/journal.pone.0162542 · DOI
  84. 10.1371/journal.pone.0183825 · DOI
  85. 10.3348/kjr.2010.11.3.304 · doi:10.3348/kjr.2010.11.3.304
  86. Glemser PA, 2017, 23Na MRI and myometry to compare eplerenone vs. glucocorticoid treatment in Duchenne dystrophy, Acta Myol Myopath Cardiomyopath Off J Mediterr Soc Myol, 36, 2

Cited by

See all 90

Metadata

Authors
Dahlqvist, J. R., Widholm, P., Leinhard, O. D., & Vissing, J.
Venue
Annals of Neurology
Publisher
Wiley
Published
2020-07
Volume
88
Issue
4
Pages
669-681
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W3028771292
Cited by
90
References
3
FWCI
3.11
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.